From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?
- 31 December 2003
- journal article
- review article
- Published by Elsevier BV in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 69 (6), 367-384
- https://doi.org/10.1016/j.plefa.2003.08.008
Abstract
No abstract availableKeywords
This publication has 207 references indexed in Scilit:
- Effects of antipsychotic treatment on membrane phospholipid metabolism in schizophreniaJournal of Neural Transmission, 2001
- Are cannabinoid receptor knockout mice animal models for schizophrenia?Medical Hypotheses, 2001
- Quantitative Messung induzierter Hautrötungen durch optische Reflexionsspektroskopie – Methodik und klinische Anwendung - Quantitative Determination of Induced Skin Reddening Using Optical Reflection Spectroscopy – Methods and Clinical ApplicationBiomedizinische Technik/Biomedical Engineering, 2001
- Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin orE-3M2HJournal of Molecular Recognition, 2001
- Oxidative Damage and SchizophreniaCNS Drugs, 2001
- Is platelet release of 2-arachidonoyl-glycerol a mediator of cognitive deficits? An endocannabinoid theory of schizophrenia and arousalMedical Hypotheses, 2000
- Attentional Inhibition in Schizophrenia and Schizotypy: A Spatial Negative Priming StudyCognitive Neuropsychiatry, 1996
- Long‐term storage of red blood cells and correlations between red cell and dietary fatty acids: Results from a pilot studyNutrition and Cancer, 1991
- Schizophrenia: The role of abnormal essential fatty acid and prostaglandin metabolismMedical Hypotheses, 1983
- A lack of essential fatty acids as a possible cause of hyperactivity in childrenMedical Hypotheses, 1981